Literature DB >> 17493897

Malignant epithelioid angiomyolipoma of the kidney.

Kuo-How Huang1, Chao-Yuan Huang, Shiu-Dong Chung, Yeong-Shiau Pu, Chia-Tung Shun, Jun Chen.   

Abstract

Angiomyolipoma (AML) is a common benign renal tumor composed of thick-walled blood vessels, smooth muscle, and adipose tissue, but the malignant epithelioid variant is extremely rare. A 78-year-old woman presented with fever and left flank pain for 3 days. Computed tomography showed a heterogeneously enhanced mass without fat density in the left kidney. Radical nephrectomy was performed and pathology showed malignant epithelioid AML with regional lymph node metastases. The tumor cells were positive for human melanosome-associated protein (HMB-45) on immunohistochemical staining. The patient died of disseminated metastases (lungs and bones) 5 months postoperatively. Epithelioid AML is a potentially aggressive tumor. The prognosis is poor in metastatic disease. HMB-45 immunoreactivity is a useful marker to make diagnosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17493897     DOI: 10.1016/s0929-6646(09)60353-3

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  12 in total

Review 1.  A suggestion for pathological grossing and reporting based on prognostic indicators of malignancies from a pooled analysis of renal epithelioid angiomyolipoma.

Authors:  Shan Zheng; Xin-gang Bi; Qing-kun Song; Zheng Yuan; Lei Guo; Hongtu Zhang; Jian-hui Ma
Journal:  Int Urol Nephrol       Date:  2015-08-15       Impact factor: 2.370

Review 2.  Clinicopathologic features of renal epithelioid angiomyolipoma: report of one case and review of literatures.

Authors:  Guobin Tan; Lei Liu; Mingning Qiu; Lieqian Chen; Jun Cao; Jianjun Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-01-01

3.  Selective arterial embolization of symptomatic and asymptomatic renal angiomyolipomas: a retrospective study of safety, outcomes and tumor size reduction.

Authors:  Florian Bardin; Olivier Chevallier; Aurélie Bertaut; Emmanuel Delorme; Morgan Moulin; Pierre Pottecher; Lucy Di Marco; Sophie Gehin; Eric Mourey; Luc Cormier; Christiane Mousson; Marco Midulla; Romaric Loffroy
Journal:  Quant Imaging Med Surg       Date:  2017-02

4.  Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma.

Authors:  Cheng-Keng Chuang; Hsin Chia Angela Lin; Han-Yu Tasi; Kun-Han Lee; Yuting Kao; Fukai Leo Chuang; Ying-Hsu Chang; Po-Hung Lin; Chung-Yi Liu; See-Tong Pang
Journal:  Int Urol Nephrol       Date:  2017-05-25       Impact factor: 2.370

5.  Renal epithelioid angiomyolipoma with a negative premelanosome marker immunoprofile: a case report and review of the literature.

Authors:  Samantha E Hohensee; Francisco G La Rosa; Petra Homer; Thomas Suby-Long; Shandra Wilson; Scott M Lucia; Kenneth A Iczkowski
Journal:  J Med Case Rep       Date:  2013-04-29

Review 6.  PEComas: the past, the present and the future.

Authors:  Guido Martignoni; Maurizio Pea; Daniela Reghellin; Giuseppe Zamboni; Franco Bonetti
Journal:  Virchows Arch       Date:  2007-12-14       Impact factor: 4.064

Review 7.  A Four-Year Follow-up Study of Renal Epithelioid Angiomyolipoma: A Multi-Center Experience and Literature Review.

Authors:  Jun H Lei; Liang R Liu; Qiang Wei; Tu R Song; Lu Yang; Hai C Yuan; Yong Jiang; Huan Xu; Sheng H Xiong; Ping Han
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

8.  Malignant renal epithelioid angiomyolipoma: A case report and review of the literature.

Authors:  Baoyin Guo; Hualin Song; Jiuling Yue; Gang Li
Journal:  Oncol Lett       Date:  2015-10-30       Impact factor: 2.967

9.  [Renal epithelioid angiomyolipoma mimicking renal carcinoma].

Authors:  Hanen Bouaziz; Ramzi Khiari; Mohamed Dridi; Samir Ghozzi; Nawfel Ben Rais
Journal:  Pan Afr Med J       Date:  2016-05-27

10.  Familial genetic tuberous sclerosis complex associated with bilateral giant renal angiomyolipoma: A case report.

Authors:  Lina Wang; Dawei Ni; Lin Zhong; Jianbo Wang
Journal:  Oncol Lett       Date:  2017-10-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.